Hello Everyone,
We are excited to announce the speaker for April ADC Working Group!
After presenting at this year's WRIB, Dr. Weiping Shao has graciously agreed to present at the AAPS monthly working group meeting for ADC.
About Dr. Weiping Shao:
Dr. Weiping Shao is currently Sr. Director and Head of Regulatory Bioanalysis at AstraZeneca, where he leads regulated bioanalysis and scientific innovation to support the development of biologics modalities from pre-clinical to clinical across all therapeutic areas. Weiping brings more than 20 years of experience and leadership in pharmaceutical / biotech industry, including his previous role as Vice President & Head of Biologics Services at a global CRO, Director & Head of Bioanalytical Operations at Regeneron, and a Research Fellow at Merck. Weiping has published more than 45 peer reviewed HQ/HI manuscripts/ commentaries, co-authored industry White Papers / Best Practices, and filed US patents. He has been active / holds leadership roles in EIP, AAPS and ISBER organizations, chairs conferences and has given numerous presentations at WRIB, AAPS and other conferences.
Meeting Details:
· Date: April 28th 2025
· Time: 3 - 4pm CDT
· Topic: "Assessing Clinical Immunogenicity of ADCs and Challenges for Next Generations"
If you are interested in joining the meeting, please use the Teams Meeting Link below:
Microsoft Teams Meeting Link
Meeting ID: 239 055 314 139
Passcode: vx3ov6we
Dial in by phone
+1 908-409-1059,,232046582# United States, Elizabeth
(833) 733-5876,,232046582# United States (Toll-free)
Find a local number
Phone conference ID: 232 046 582#
------------------------------
Soumya Mohana Sundaram M.S.
Associate Director
Celerion
Lincoln NE
[email protected]
Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
------------------------------